ProjectADMEC
Basic data
Title:
ADMEC
Duration:
01/10/2014 to 31/03/2018
Abstract / short description:
Prospective randomized trial of an adjuvant therapy of completely resected Merkel Cell Carcinoma (MCC) with 3mg/kg BW Ipilimumab (Yervoy®) every 3 weeks for 12 weeks versus observation
Keywords:
Merkelzellkarzinom (Merkel Cell Carcinoma)
Involved staff
Managers
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Contact persons
Faculty of Medicine
University of Tübingen
University of Tübingen
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
Essen, Nordrhein-Westfalen, Germany